Chun L. Gan

Butterfield St
Herston, QLD 4006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Treatment-refractory immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in the setting of adjuvant pembrolizumab for resected stage IIC melanoma: a case report.

Treatment-refractory immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in the setting of adjuvant pembrolizumab for resected stage IIC melanoma: a case report.

Journal: Journal of medical case reports

Published: August 30, 2024

Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series.

Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series.

Journal: Asia-Pacific journal of clinical oncology

Published: August 21, 2024

The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort.

The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort.

Journal: European urology focus

Published: July 31, 2023

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 27, 2023

Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma.

Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer

Published: September 29, 2022

Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.

Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.

Journal: European urology

Published: May 19, 2022

Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy.

Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 05, 2022

Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Journal: European urology open science

Published: December 17, 2021

Clinicopathological Correlates of Dysplastic Sessile Serrated Lesion: A Prospective Cohort Study With a High Detection Rate.

Clinicopathological Correlates of Dysplastic Sessile Serrated Lesion: A Prospective Cohort Study With a High Detection Rate.

Journal: Gastro hep advances

Published: November 15, 2021

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.

Journal: European urology

Published: May 20, 2021

68 Ga-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer.

68 Ga-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer.

Journal: Asia-Pacific journal of clinical oncology

Published: February 18, 2021

Case - Acquired hemophilia A in a patient with metastatic castration-resistant prostate cancer.

Case - Acquired hemophilia A in a patient with metastatic castration-resistant prostate cancer.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: February 16, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026